IP Library Granted Patent US 9,463,212
Granted Patent B2
US 9,463,212 · App. 14/677,681 · Granted Oct 11, 2016

Antimicrobial and antiviral composition

Inventor: John A. Willimann (Chevy Chase, MD)
Assignee: GLOBAL LIFE TECHNOLOGIES CORP.
A61K36/889A61K9/0043A61K9/08A61K31/015A61K31/045A61K31/14A61K31/20A61K33/40A61K36/185A61K36/752A61K45/06A61M35/003A61M35/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,212
App. No.
14/677,681
Granted
Oct 11, 2016
Kind
B2
Abstract

A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity including application of a solution of an antimicrobial, antiviral and antifungal composition to the anterior vestibular region of the nares. The antimicrobial, antiviral and antifungal solution includes ethyl alcohol as an active ingredient. Various embodiments may also include one or more of the following additional ingredients: orange oil, coconut oil; soy oil; emu oil; grapefruit seed extract; glycine soja; simmondsia chinensis (Jojoba); lauric acid; aloe vera; and a preservative, such as benzalkonium chloride and vitamin E.

Claims (7)

1. A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity of a human in need thereof consisting essentially of administering to said human's nose an applicator with a composition consisting essentially of ethanol and a component selected from the group consisting of orange oil, jojoba oil, vitamin E, coconut oil, benzalkonium chloride and lauric acid, wherein said number of microorganisms are reduced from entering the nose of the human.

2. The method of claim 1 , wherein the applicator is a porous tip for delivering the composition to the human's nose.

3. The method of claim 1 , wherein the applicator is a porous tip and a breakable glass ampoule.

4. The method of claim 1 , wherein the applicator is a flocked swab.

5. The method of claim 1 , wherein the applicator is a cotton swab.

6. The method of claim 1 , wherein the applicator is a human finger.

7. The method of claim 1 , wherein the applicator is a device structured to hold the composition and apply the composition to the inner surface of the nostril openings of the human's nose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: WILLIMANN, JOHN A.
To: GLOBAL LIFE TECHNOLOGIES CORP.
Reel/Frame 039186/0533 →
Continuity (6)
Continuation In Part 14318972 · Jun 30, 2014
Continuation In Part 13447912 · Apr 16, 2012
Continuation 12658116 · Feb 1, 2010
Division 11906640 · Oct 3, 2007
Continuation In Part 11189242 · Jul 26, 2005
Related Publication 20150306166A1 · Oct 29, 2015